CHGCY:OTCMKTS
Chugai Pharmaceutical ADR
19,24 $
arrow_upward
+0,10%(+0,020) 1D
14 қаз., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CHGCY...
Open
18,56 $
High
19,25 $
Low
18,33 $
Mkt. cap
10,52 трлн
Avg. vol.
318,06 м.
Volume
336,16 м.
52-wk high
34,84 $
52-wk low
18,33 $
Beta
0,56
Shares outstanding
3,36 млрд
No. of employees
5 мың
Open
18,56 $
High
19,25 $
Low
18,33 $
Mkt. cap
10,52 трлн
Avg. vol.
318,06 м.
Volume
336,16 м.
52-wk high
34,84 $
52-wk low
18,33 $
Beta
0,56
Shares outstanding
3,36 млрд
No. of employees
5 мың
News stories
From web sources and news partners
ad-hoc-news.de
·
17 сағат бұрын
Chugai reports vamikibart data for Chugai Pharmaceutical stock
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical ADR
CEOOsamu Okuda
Employees5,1 мың
Founded1925 ж. 10 нау.
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp